Reproducibility of high-resolution optical coherence tomography in multiple sclerosis

Stephanie B. Syc, Christina V. Warner, Girish S. Hiremath, Sheena K. Farrell, John N. Ratchford, Amy Conger, Teresa Frohman, Gary Cutter, Laura J. Balcer, Elliot Frohman, Peter A. Calabresi

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Optical coherence tomography (OCT) is a non-invasive method to quantify neurodegeneration as an outcome in multiple sclerosis clinical trials; however, no data exist on Cirrus spectral domain optical coherence tomography (SD-OCT) reproducibility in patients with multiple sclerosis. The objective of this study was to determine the protocol for achieving optimal inter-visit, inter-rater, and intra-rater reproducibility for studies performed on healthy controls and multiple sclerosis patients utilizing novel high-definition SD-OCT. This is a prospective study of inter-visit, inter-rater, and intra-rater reproducibility in multiple sclerosis patients (n = 58) and healthy controls (n = 32) on Cirrus-HD SD-OCT. Excellent reproducibility of average and quadrantic retinal nerve fiber layer (RNFL) thickness values, average macular thickness (AMT), and total macular volume (TMV) [measured by intraclass correlation coefficient (ICC)] was found for inter-visit (healthy controls: mean RNFL = 0.97, quadrant range = 0.92-0.97, AMT = 0.97, TMV = 0.92), inter-rater (MS: mean RNFL = 0.97, quadrant = 0.94-0.98, AMT = 0.99, TMV = 0.96; healthy controls: mean RNFL = 0.97, quadrant = 0.94-0.97, AMT = 0.98, TMV = 0.99), and intra-rater (MS patients: mean RNFL = 0.99, quadrant = 0.83-0.99, AMT = 0.97, TMV = 0.98) reproducibility. The reproducibility of retinal measures derived by Cirrus HD-OCT, especially quadrantic values, is excellent. Specific procedures for OCT acquisition and analysis of retinal imaging metrics using SD-OCT technology may improve the application of this novel technology in multiple sclerosis.

Original languageEnglish (US)
Pages (from-to)829-839
Number of pages11
JournalMultiple Sclerosis
Volume16
Issue number7
DOIs
StatePublished - 2010

Fingerprint

Optical Coherence Tomography
Multiple Sclerosis
Nerve Fibers
Technology
Clinical Trials
Prospective Studies

Keywords

  • axonal loss
  • Demyelinating disease (CNS)
  • multiple sclerosis
  • neuro-ophthalmology
  • optic nerve
  • outcome measurement

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Syc, S. B., Warner, C. V., Hiremath, G. S., Farrell, S. K., Ratchford, J. N., Conger, A., ... Calabresi, P. A. (2010). Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Multiple Sclerosis, 16(7), 829-839. https://doi.org/10.1177/1352458510371640

Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. / Syc, Stephanie B.; Warner, Christina V.; Hiremath, Girish S.; Farrell, Sheena K.; Ratchford, John N.; Conger, Amy; Frohman, Teresa; Cutter, Gary; Balcer, Laura J.; Frohman, Elliot; Calabresi, Peter A.

In: Multiple Sclerosis, Vol. 16, No. 7, 2010, p. 829-839.

Research output: Contribution to journalArticle

Syc, SB, Warner, CV, Hiremath, GS, Farrell, SK, Ratchford, JN, Conger, A, Frohman, T, Cutter, G, Balcer, LJ, Frohman, E & Calabresi, PA 2010, 'Reproducibility of high-resolution optical coherence tomography in multiple sclerosis', Multiple Sclerosis, vol. 16, no. 7, pp. 829-839. https://doi.org/10.1177/1352458510371640
Syc SB, Warner CV, Hiremath GS, Farrell SK, Ratchford JN, Conger A et al. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Multiple Sclerosis. 2010;16(7):829-839. https://doi.org/10.1177/1352458510371640
Syc, Stephanie B. ; Warner, Christina V. ; Hiremath, Girish S. ; Farrell, Sheena K. ; Ratchford, John N. ; Conger, Amy ; Frohman, Teresa ; Cutter, Gary ; Balcer, Laura J. ; Frohman, Elliot ; Calabresi, Peter A. / Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. In: Multiple Sclerosis. 2010 ; Vol. 16, No. 7. pp. 829-839.
@article{2a0ff7b7f5fd4a69b12f5b9bdc3a57a9,
title = "Reproducibility of high-resolution optical coherence tomography in multiple sclerosis",
abstract = "Optical coherence tomography (OCT) is a non-invasive method to quantify neurodegeneration as an outcome in multiple sclerosis clinical trials; however, no data exist on Cirrus spectral domain optical coherence tomography (SD-OCT) reproducibility in patients with multiple sclerosis. The objective of this study was to determine the protocol for achieving optimal inter-visit, inter-rater, and intra-rater reproducibility for studies performed on healthy controls and multiple sclerosis patients utilizing novel high-definition SD-OCT. This is a prospective study of inter-visit, inter-rater, and intra-rater reproducibility in multiple sclerosis patients (n = 58) and healthy controls (n = 32) on Cirrus-HD SD-OCT. Excellent reproducibility of average and quadrantic retinal nerve fiber layer (RNFL) thickness values, average macular thickness (AMT), and total macular volume (TMV) [measured by intraclass correlation coefficient (ICC)] was found for inter-visit (healthy controls: mean RNFL = 0.97, quadrant range = 0.92-0.97, AMT = 0.97, TMV = 0.92), inter-rater (MS: mean RNFL = 0.97, quadrant = 0.94-0.98, AMT = 0.99, TMV = 0.96; healthy controls: mean RNFL = 0.97, quadrant = 0.94-0.97, AMT = 0.98, TMV = 0.99), and intra-rater (MS patients: mean RNFL = 0.99, quadrant = 0.83-0.99, AMT = 0.97, TMV = 0.98) reproducibility. The reproducibility of retinal measures derived by Cirrus HD-OCT, especially quadrantic values, is excellent. Specific procedures for OCT acquisition and analysis of retinal imaging metrics using SD-OCT technology may improve the application of this novel technology in multiple sclerosis.",
keywords = "axonal loss, Demyelinating disease (CNS), multiple sclerosis, neuro-ophthalmology, optic nerve, outcome measurement",
author = "Syc, {Stephanie B.} and Warner, {Christina V.} and Hiremath, {Girish S.} and Farrell, {Sheena K.} and Ratchford, {John N.} and Amy Conger and Teresa Frohman and Gary Cutter and Balcer, {Laura J.} and Elliot Frohman and Calabresi, {Peter A.}",
year = "2010",
doi = "10.1177/1352458510371640",
language = "English (US)",
volume = "16",
pages = "829--839",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "7",

}

TY - JOUR

T1 - Reproducibility of high-resolution optical coherence tomography in multiple sclerosis

AU - Syc, Stephanie B.

AU - Warner, Christina V.

AU - Hiremath, Girish S.

AU - Farrell, Sheena K.

AU - Ratchford, John N.

AU - Conger, Amy

AU - Frohman, Teresa

AU - Cutter, Gary

AU - Balcer, Laura J.

AU - Frohman, Elliot

AU - Calabresi, Peter A.

PY - 2010

Y1 - 2010

N2 - Optical coherence tomography (OCT) is a non-invasive method to quantify neurodegeneration as an outcome in multiple sclerosis clinical trials; however, no data exist on Cirrus spectral domain optical coherence tomography (SD-OCT) reproducibility in patients with multiple sclerosis. The objective of this study was to determine the protocol for achieving optimal inter-visit, inter-rater, and intra-rater reproducibility for studies performed on healthy controls and multiple sclerosis patients utilizing novel high-definition SD-OCT. This is a prospective study of inter-visit, inter-rater, and intra-rater reproducibility in multiple sclerosis patients (n = 58) and healthy controls (n = 32) on Cirrus-HD SD-OCT. Excellent reproducibility of average and quadrantic retinal nerve fiber layer (RNFL) thickness values, average macular thickness (AMT), and total macular volume (TMV) [measured by intraclass correlation coefficient (ICC)] was found for inter-visit (healthy controls: mean RNFL = 0.97, quadrant range = 0.92-0.97, AMT = 0.97, TMV = 0.92), inter-rater (MS: mean RNFL = 0.97, quadrant = 0.94-0.98, AMT = 0.99, TMV = 0.96; healthy controls: mean RNFL = 0.97, quadrant = 0.94-0.97, AMT = 0.98, TMV = 0.99), and intra-rater (MS patients: mean RNFL = 0.99, quadrant = 0.83-0.99, AMT = 0.97, TMV = 0.98) reproducibility. The reproducibility of retinal measures derived by Cirrus HD-OCT, especially quadrantic values, is excellent. Specific procedures for OCT acquisition and analysis of retinal imaging metrics using SD-OCT technology may improve the application of this novel technology in multiple sclerosis.

AB - Optical coherence tomography (OCT) is a non-invasive method to quantify neurodegeneration as an outcome in multiple sclerosis clinical trials; however, no data exist on Cirrus spectral domain optical coherence tomography (SD-OCT) reproducibility in patients with multiple sclerosis. The objective of this study was to determine the protocol for achieving optimal inter-visit, inter-rater, and intra-rater reproducibility for studies performed on healthy controls and multiple sclerosis patients utilizing novel high-definition SD-OCT. This is a prospective study of inter-visit, inter-rater, and intra-rater reproducibility in multiple sclerosis patients (n = 58) and healthy controls (n = 32) on Cirrus-HD SD-OCT. Excellent reproducibility of average and quadrantic retinal nerve fiber layer (RNFL) thickness values, average macular thickness (AMT), and total macular volume (TMV) [measured by intraclass correlation coefficient (ICC)] was found for inter-visit (healthy controls: mean RNFL = 0.97, quadrant range = 0.92-0.97, AMT = 0.97, TMV = 0.92), inter-rater (MS: mean RNFL = 0.97, quadrant = 0.94-0.98, AMT = 0.99, TMV = 0.96; healthy controls: mean RNFL = 0.97, quadrant = 0.94-0.97, AMT = 0.98, TMV = 0.99), and intra-rater (MS patients: mean RNFL = 0.99, quadrant = 0.83-0.99, AMT = 0.97, TMV = 0.98) reproducibility. The reproducibility of retinal measures derived by Cirrus HD-OCT, especially quadrantic values, is excellent. Specific procedures for OCT acquisition and analysis of retinal imaging metrics using SD-OCT technology may improve the application of this novel technology in multiple sclerosis.

KW - axonal loss

KW - Demyelinating disease (CNS)

KW - multiple sclerosis

KW - neuro-ophthalmology

KW - optic nerve

KW - outcome measurement

UR - http://www.scopus.com/inward/record.url?scp=77955030770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955030770&partnerID=8YFLogxK

U2 - 10.1177/1352458510371640

DO - 10.1177/1352458510371640

M3 - Article

C2 - 20530512

AN - SCOPUS:77955030770

VL - 16

SP - 829

EP - 839

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 7

ER -